Exchange Traded Concepts’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$282K Buy
+4,094
New +$272K ﹤0.01% 1261
2025
Q4
Sell
-4,438
Closed -$279K 1643
2025
Q3
$279K Sell
4,438
-107
-2% -$6.33K ﹤0.01% 1098
2025
Q2
$259K Buy
4,545
+121
+3% +$6.58K ﹤0.01% 1051
2025
Q1
$248K Sell
4,424
-266
-6% -$15.9K ﹤0.01% 914
2024
Q4
$288K Buy
4,690
+141
+3% +$9.12K 0.01% 911
2024
Q3
$304K Buy
+4,549
New +$309K 0.01% 867

Other funds holding UTMD

Exchange Traded Concepts's UTMD Position: Q2 2026 in Review

Exchange Traded Concepts opened a new position in Utah Medical Products (UTMD) in Q2 2026: 4,094 shares worth $282K. The stake represents ﹤0.01% of the portfolio and ranks #1261 among its holdings. This is a return to the name: Exchange Traded Concepts previously reported a position in UTMD as recently as Q3 2025.

Exchange Traded Concepts first reported a position in UTMD in Q3 2024 and has held it in 6 quarters since. The position peaked at $304K in Q3 2024. 17 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

  • Exchange Traded Concepts held 4,094 shares of Utah Medical Products worth $282K as of Q2 2026.
  • Utah Medical Products was a new Exchange Traded Concepts position in Q2 2026.
  • Utah Medical Products made up ﹤0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #1261 holding.
  • Exchange Traded Concepts first reported a position in Utah Medical Products in Q3 2024 and has held it in 6 quarters since.
  • Exchange Traded Concepts's Utah Medical Products position peaked at $304K in Q3 2024.
  • 17 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.